Literature DB >> 15309391

Predictive potential of cavum septi pellucidi (CSP) in schizophrenics, alcoholics and persons with past head trauma. A post-mortem study.

Branislav Filipović1, Milan Prostran, Nikola Ilanković, Branka Filipović.   

Abstract

The increased presence of cavum septi pellucidi (CSP) was reported among people suffering from schizophrenia, alcoholism or it could be a remnant of an old head trauma. We have tried to compare not only prevalences, but also lengths, widths and depths of the obtained cava in an effort to emphasize the importance of linear parameters in routine diagnostics. On 479 cadavers, 310 male and 169 female, aged 22 to 89; 110 brains had a CSP: 40 persons had no data about prior neuropsychiatric disease, 25 were schizophrenics, 25 alcoholics and 20 received a serious head blow during their lifetime. The prevalence of CSP in the entire group was 22.96%; among normal persons 10.61%; in schizophrenics 83.33%, in alcoholics 58.14 % and in persons with sustained prior head trauma 68.96%. There was a statistically significant difference in ratings, lengths and widths of CSP between schizophrenics, alcoholics, head traumatized and normals. Both length and width were revealed as parameters of importance for CSP selection. CSP is more frequent, longer and wider in persons who are suffering from schizophrenia, alcohol addicts and those who had sustained one or several head blows in the past. Its linear parameters are advisable to be measured.

Entities:  

Mesh:

Year:  2004        PMID: 15309391     DOI: 10.1007/s00406-004-0483-4

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  23 in total

1.  CONGENITAL DILATATIONS OF THE SEPTUM PELLUCIDUM.

Authors:  H SCHUNK
Journal:  Radiology       Date:  1963-10       Impact factor: 11.105

2.  Five boxers.

Authors:  J D SPILLANE
Journal:  Br Med J       Date:  1962-11-10

3.  Association of Chiari I malformation, mental retardation, speech delay, and epilepsy: a specific disorder?

Authors:  S Grosso; R Scattolini; G Paolo; R M Di Bartolo; G Morgese; P Balestri
Journal:  Neurosurgery       Date:  2001-11       Impact factor: 4.654

4.  Incidence of cavum septum pellucidum in adults: a sign of boxer's encephalopathy.

Authors:  B Bogdanoff; H M Natter
Journal:  Neurology       Date:  1989-07       Impact factor: 9.910

5.  The cavum septi pellucidi in term and preterm newborn infants.

Authors:  S H Mott; J B Bodensteiner; W C Allan
Journal:  J Child Neurol       Date:  1992-01       Impact factor: 1.987

6.  Comparative post-mortem study of cavum septi pellucidi in alcoholics, schizophrenics and aggressive persons.

Authors:  B Filipović; G Teofilovski-Parapid; M Stojicić
Journal:  Folia Morphol (Warsz)       Date:  2000       Impact factor: 1.183

7.  Pattern of brain morphology in patients with schizophrenia and large cavum septi pellucidi.

Authors:  P Nopoulos; V Swayze; N C Andreasen
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1996       Impact factor: 2.198

8.  Cavum septi pellucidi and cavum vergae in normal and developmentally delayed populations.

Authors:  J B Bodensteiner; G B Schaefer; J M Craft
Journal:  J Child Neurol       Date:  1998-03       Impact factor: 1.987

9.  Wide cavum septum pellucidum: a marker of disturbed brain development.

Authors:  J B Bodensteiner; G B Schaefer
Journal:  Pediatr Neurol       Date:  1990 Nov-Dec       Impact factor: 3.372

Review 10.  Dementia pugilistica and cavum septi pellucidi: born to box?

Authors:  J B Bodensteiner; G B Schaefer
Journal:  Sports Med       Date:  1997-12       Impact factor: 11.136

View more
  8 in total

1.  Cavum Septi Pellucidi in Symptomatic Former Professional Football Players.

Authors:  Inga K Koerte; Jakob Hufschmidt; Marc Muehlmann; Yorghos Tripodis; Julie M Stamm; Ofer Pasternak; Michelle Y Giwerc; Michael J Coleman; Christine M Baugh; Nathan G Fritts; Florian Heinen; Alexander Lin; Robert A Stern; Martha E Shenton
Journal:  J Neurotrauma       Date:  2015-12-15       Impact factor: 5.269

2.  The hormonal environment in utero as a potential aetiological agent for schizophrenia.

Authors:  Marco Procopio; Russel J E Davies; Paul Marriott
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-08-29       Impact factor: 5.270

Review 3.  The Lateral Ventricles: A Detailed Review of Anatomy, Development, and Anatomic Variations.

Authors:  C L Scelsi; T A Rahim; J A Morris; G J Kramer; B C Gilbert; S E Forseen
Journal:  AJNR Am J Neuroradiol       Date:  2020-02-20       Impact factor: 3.825

4.  Volumetric analysis of septal region in schizophrenia and affective disorder.

Authors:  Ralf Brisch; Hans-Gert Bernstein; Dieter Krell; Renate Stauch; Kurt Trübner; Henrik Dobrowolny; Siegfried Kropf; Hendrik Bielau; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-16       Impact factor: 5.270

5.  The relationship between cavum septum pellucidum and psychopathic traits in a large forensic sample.

Authors:  Dana Crooks; Nathaniel E Anderson; Matthew Widdows; Nia Petseva; Michael Koenigs; Charles Pluto; Kent A Kiehl
Journal:  Neuropsychologia       Date:  2018-03-12       Impact factor: 3.139

6.  Increased incidence and size of cavum septum pellucidum in children with chromosome 22q11.2 deletion syndrome.

Authors:  Elliott A Beaton; Yufeng Qin; Vy Nguyen; Joel Johnson; Joseph D Pinter; Tony J Simon
Journal:  Psychiatry Res       Date:  2010-01-13       Impact factor: 3.222

7.  Enlarged cavum septum pellucidum as a neurodevelopmental marker in adolescent-onset opiate dependence.

Authors:  Jaeuk Hwang; Jieun E Kim; Marc J Kaufman; Perry F Renshaw; Sujung Yoon; Deborah A Yurgelun-Todd; Yera Choi; Chansoo Jun; In Kyoon Lyoo
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

8.  Late-onset schizophrenia with isolated cavum vergae: Case report and literature review.

Authors:  Rashmin Achalia; K S Bhople; Pankaj Ahire; Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2014-10       Impact factor: 1.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.